These results have been used as a type of case control study to assess genes for breast cancer associations and the increase in actionable gene identification other than BRCA1 and BRCA2 [1,2,3,4,5,6,7,8,9,10]. This evidence concerns the gene BRCA1 and breast carcinoma.